InhibOx Awarded Prestigious FP7 Grant
25th July 2013
InhibOx, the computer-aided drug design company, has been awarded funding of €1 million by the European Commission’s 7th Framework Programme as part of a €4.1 million consortium project for the preclinical development of novel treatments for multi-drug resistant bacterial infections. InhibOx was spun out of Oxford University Innovation Ltd in 2001.
For more information
© Oxford University Innovation